CDK6 and breast carcinoma: In the STAT3 and Cyclin D pathways, CDK6 could up-regulate the transcription of P16 and the expression of VEGF-A that can promote angiogenesis, contributing to the progression and drug resistance of breast cancer (32, 34) (Figure 2, Table 1).